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Ultra-sensitive in situ visualization of active glucocerebrosidase molecules 
 
Witte M.D., Kallemeijn W.W., Aten J., Li K.Y., Strijland A., Donker-Koopman W.E., van 
den Nieuwendijk A.M.C.H., Bleijlevens B., Kramer G., Florea B.I., Hooibrink B., Hollak 
C.E.M., Ottenhoff R., Boot R.G., van der Marel G.A., Overkleeft H.S., Aerts J.M.F.G. 
 
Supplementary results 
Synthesis of the probes 
KY170 4, and fluorescent probes MDW933 5 and MDW941 6 were synthesized as follows. First, core 
carbocycle 10 was synthesized in 7 steps from D-xylose as described (1). Selective tosylation of the 
primary alcohol in 1 by treatment with p-toluenesulfonyl chloride in CH2Cl2 followed by substitution 
of the tosylate with sodium azide afforded azido alcohol 11 in 72%. The benzyl groups in 11 were 
removed under the agency of BCl3 prior to epoxidation. The resulting free hydroxyls were protected as 
the corresponding benzoyl protective groups using benzoyl chloride in pyridine. Epoxidation of 
cyclohexene 12 using in situ formed methyl(trifluoromethyl)dioxirane gave epoxides 13 and 14 as a 
separable mixture. Deprotection with sodium methoxide in methanol gave 8-deoxy-8-
azidocyclophellitol (KY170, 4). BODIPY Green-alkyne 15 (green fluorescent) or BODIPY Red-
alkyne 16 (red fluorescent) was conjugated to KY170 4 using copper–catalyzed click chemistry, 
giving MDW933 5 and MDW941 6 respectively. Non-reactive control probes MDW1064 8 and 
MDW1065 9 were synthesized by removing the protective groups in azido alcohol 11 with BCl3 and 
subsequent conjugation to either BODIPY Green 15 or BODIPY Red 16.  
 
Supplementary Scheme 1. Synthesis of KY170 4, MDW933 5 and MDW941 6. 
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Reagents and conditions: (a) i) p-TosCl, Et3N, CH2Cl2, 0°C; ii) NaN3, DMF, 60°C, 71%; (b) i) BCl3, 
CH2Cl2, -78°C, ii) BzCl, pyridine, 70%; (c) CF3COCH3, Oxone, NaHCO3, MeCN/H2O, 13: 49%, 14: 
20%; (d) NaOMe, MeOH, 75%; (e) 15 or 16, CuSO4 (10 mol%), sodium ascorbate (15 mol%), 
Tol/tert-BuOH/H2O, 90°C, MDW933 5: 56%, MDW941 6: 77%; (f) BCl3, CH2Cl2, -78°C; (g) 15 or 
16, CuSO4 (10 mol%), sodium ascorbate (15 mol%), DMF, MDW1064 8: 72%, MDW1065 9: 70%. 
 
Determination of inhibition constants  
Previously discontinuous methods have been used to determine the inhibition constants of glycosidase 
inhibitors. This method however proved to be unsuitable for the determination of the inhibition 
constants of KY170 4, MDW933 5 and MDW941 6 due to their high affinity/fast binding. Therefore 
the inhibition constants have been determined in a continuous substrate assay which was first 
described in 1982 (2) and has recently been reappraised in 2010 (3). In these experiments, inhibition of 
the enzyme and hydrolysis of the substrate proceed concurrently making the situation slightly more 
complex than the discontinuous (Scheme 2). The time-dependent interaction of inhibitor (I) with free 
β-glucosidase (E) was considered to occur in separate stages (A). A rapid reversible interaction is 
followed by a slower, irreversible reaction that transforms the reversible enzyme-inhibitor complex 
(EI) into an irreversible enzyme-inhibitor complex (EI*) (Supplementary Scheme 2). Progress curves 
were obtained (Supplementary Figure 1a) and apparent rate constant k’ was plotted versus the 
concentration (Supplementary Figure 1b) to obtain estimates of the Ki (equilibrium constant) and ki 
(rate constant) 
 
Supplementary Scheme 2. Schematic representation of the process occurring during a continuous 
substrate assay. 
 



































































































































































































































Supplementary Figure 1. Inhibition of GBA by probes. (A) Progress curves. An average of three 
individual measurements which is corrected for the blank and corrected to zero is represented. (B) k’ 
versus [I]0 plots. Data points represent mean of nine individual k’ ± s.e.m. Solid lines represent best fit 
according to the described equitation. Dashed lines represent 95% intervals.  
 
Molecular docking 
Molecular docking was performed with KY170 4, MDW933 5 and MDW941 6 as ligands. MDW933 
5 and MDW941 6 revealed to bind tightly to the GBA active site (Supplementary Figure 2). Both 
probes displayed free binding energies of ~8 kcal/mol. For both ligands we observed binding of the 
polar cyclophellitol head group in the active site pocket, with the epoxide being within 4 Angstrom of 
E340. The region immediately outside the active site pocket on the protein surface accommodated the 
hydrophobic tails. Inspection of binding showed tight binding of the hydrophobic part of the ligand 
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with this part of the protein. Binding of KY170 4 was much weaker in the range of 5 kcal/mol, further 




Supplementary Figure 2. Molecular docking of MDW933 and MDW941. Lowest energy 
conformers with rotatable bonds docked on crystal structure of glucocerebrosidase (pdb 2VE3). 
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Inhibitor molecule is shown as sticks, GBA as semi-transparent space-filling model, and active-site 
residues E235 and E340 as dark-blue sticks (left and right, respectively) (A). Docking of MDW933 
shows two common docking conformations (C, D) of -8.2 and -8.1 kcal/mol, docking of MDW941 
resulted in -9.6 kcal/mol binding affinity (B). (E-H) Docking comparison with CBE-bound GBA 
(2VT0). Top (E) and side (G) view of CBE docked on crystal structure 2V3E (E340, dark red; E235, 
dark blue; CBE, dark green) on top of covalent-bound CBE crystal structure 2VT0 (E340, pink; E235, 
light blue; CBE, pale green). Top (F) and side (H) view of an overlay of MDW933 (bright green). 
 
Supplementary Figure 3. Mass spectrometric analysis of covalently labeled GBA. (A) Schematic 
representation of the experiment. Recombinant GBA labeled with KY170 4 is digested with trypsin 
and analyzed by LC tandem MS (upper path). To release the label and to install the hydroxamic acid 
residue, GBA labeled with MDW933 5 is treated with hydroxylamine prior to tryptic digestion and 
analysis by LC-MS/MS (lower path). KY170 4 (B) and MDW933 5 (C) are covalently linked to E340
 
in recombinant GBA. One peptide that was selected for fragmentation in the tryptic digest of GBA 
labeled with 4 had a parent mass (2071.99 amu) and one peptide that was selected for fragmentation in 
the tryptic digest of GBA labeled with 5 and treated with hydroxylamine had a parent mass (1885.92 
amu). The mass of these peptides was 201.09 amu and 15.02 amu increased compared to the theoretic 
mass (1870.90 amu) of the sequence of the tryptic peptide containing residue E340 (shown in bold 
red). This is in accordance with the addition of the mass of respectively KY170 4 (201.08 amu) and 
hydroxylamine (15.01 amu). Furthermore it is clear from the tandem mass spectra shown, that the 
adduct mass is localized at the glutamic acid residue of the peptide resulting in a delta-mass of 329.03 
amu between y6, y7 and 330.14 amu between b10, b11, and a delta-mass of 144.03 amu between y6, 
y7 and 143.98 amu between b10, b11 for respectively KY170 4 (B) and MDW933 5 (C). This is 
consistent with the mass of glutamic acid covalently linked to KY170 4 (330.12 amu) and 
hydroxylamine (144.05 amu) at that site. Ccam, cysteine residue with carbamidometyl modification. 
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Supplementary Figure 4. Labeling of GBA in cell lysates. (a) MDW933 5 (1 nM to 10 
µM) selectively labeled GBA in fibroblast (left), COS cell lysate (middle) and HEP2G cell 



































Supplementary Figure 5. Indenfication of the 160 kDa protein. (a) Labeling of lactase by 
MDW933 5 in homogenates of the duodenum of mice in the presence or absence of lactose 
(250 mM). (b) Quantification of the observed fluorescent signal. Data represent mean values 
± s.d. 
 
Cellular uptake of the probes 
To identify the mechanism of entry of the probes, we performed a temperature experiment. 
We incubated cells with a serial dilution of MDW933 5 either at 18°C, a temperature at which 
endocytosis is blocked, or 37°C for 2 hours. We harvested the cells and determined the 
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residual activity using a fluorogenic substrate assay. The residual activities showed that the 
temperature did not have an pronounced effect on in situ inhibition. At both temperatures, 10 
nM MDW933 5 blocked glucocerebrosidase activity in situ (SI Fig 6). We therefore exclude 
that the uptake is solely by endocytosis. 























Supplementary Figure 6. In situ inhibition of GBA by MDW933 5 at 18°C (black 
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Supplementary Figure 7. Representative spectral imaging micrographs of control (left 
column) and gaucher (right column) cells labeled with MDW941 6. First row of panels 
represent a heat map of the autofluorescence. The second row of panels show a heat map of 
the observed BODIPY-fluorescence of GBA labeled with MDW941 6 (unmixed and 
separated from the autofuorescence). The third row shows a heat map of the Alexa488-
fluorescence of GBA visualized with monoclonal Ab 8E4 (unmixed and separated from the 
autofuorescence). In the fourth row an overlay of the unmixed and corrected signals of 
BODIPY and Alexa488 fluorescence is shown. Scale bar represents 20 µM. 
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Supplementary Figure 8. Representative spectral imaging micrographs of cells labeled 
with MDW941 6 or control probe MDW1065 9 in the presence or absence of CBE 2. The 
left column shows the autofluorescence and the right column shows the unmixed BODIPY 
fluorescence signal. Upper row, micrographs of cells treated with MDW941 6 in the absence 
of CBE 2 are shown. The second row of micrographs shows the cells treated with MDW941 6 
in the presence of CBE 2 (3 mM). The third row shows micrographs obtained after labeling 
cells with the non-reactive control probe MDW1065 9. In the final row, micrographs of cells 
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Supplementary Figure 9. Labeling of GBA in Gaucher and control spleen. Tissue 
homogenates were treated with 0, 10, 50 and 100 nM MDW933 5 for 60 min.  
1000 100 10 1 0.1 0.01 0[5] (μM) 




























Supplementary Figure 10. The reversibility of isofagomine inhibition. Recombinant GBA 
attached to monoclonal antibody 8E4 immobilized to Sepharose beads was pre-incubated for 15 
min with increasing concentrations of isofagomine at pH 5.2 in the presence of taurocholate (0.2 
% w/v) and Triton X-100 (0.1 % v/v). The bead suspension was washed with the same buffer or 
not and subsequently incubated for 15 min with 10 nM MDW933 5. 
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Supplementary Figure 11. Uncut gel images of Figure 2a, 2b, 2c, 2e and 2f are shown as 
respectively a, b, c, d, e. 
 
Supplementary Figure 12. Uncut gel images of Figure 3d are shown. 
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Supplementary Figure 13. Uncut gel images of Figure 4a are shown. 
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Supplementary Figure 14. Uncut gel images of Figure 5a. Left: fluorescent read-out. Right: 
GBA is visualized using Western blotting 
 




All reagents were of a commercial grade and were used as received unless stated otherwise. 
Isofagomine 1 (4), cyclophellitol 3 (1) and BODIPY alkyne green 15 and red 16 (5) were synthesized 
as described in literature and their spectral data was in accordance with those reported in literature. 
The AMP-DNM 7 used in this research was from a previously synthesized batch (6). Diethyl ether 
(Et2O), ethyl acetate (EtOAc), light petroleum ether and toluene were obtained from Riedel-de Haën. 
Acetonitrile, dichloromethane, dimethylformamide (DMF), methanol (MeOH), pyridine, 
tetrahydrofuran (THF) were purchased from Biosolve. Dichloromethane was distilled from CaH2 and 
THF was distilled over LiAlH4 prior to use. All reactions were performed under an inert atmosphere or 
Argon unless stated otherwise. Solvents used for flash chromatography were of pro analysi quality.  
Reactions were monitored by TLC analysis using Merck aluminum sheets precoated with silica gel 60 
with detection by UV-absorption (254 nm) and by spraying with a solution of (NH4)6Mo7O24·H2O (25 
g/L) and (NH4)4Ce(SO4)4·H2O (10 g/L) in 10% aqueous sulfuric acid followed by charring at ~150°C 
or by spraying with 20% sulfuric acid in ethanol followed by charring at ~150°C. Column 
chromatography was performed using either Baker- or Screening Device silica gel in the indicated 
solvents. 1H NMR and 13C NMR spectra were recorded on a Bruker DMX-400 (400/100 MHz) or a 
Bruker AV-400 (400/100 MHz) spectrometer in the given solvent. Chemical shifts are reported as  δ-
values in ppm relative to the chloroform residual solvent peak or tetramethylsilane (TMS) as internal 
standard. Coupling constants are given in Hz. All given 13C spectra are proton decoupled. Spin 
multiplicities are given as s, d, dd, ddd, dddd, dt, t, td, q and m. High resolution mass spectra were 
recorded with a LTQ Orbitrap (Thermo Finnigan). LC/MS analysis was performed on a Jasco HPLC-
system (detection simultaneously at 214 nm and 254 nm) equipped with an analytical Alltima C18 
column (Alltech, 4.6 mmD × 250 mmL, 5μ particle size) in combination with buffers A: H2O, B: 
acetonitrile and C: 1% aq. TFA and coupled to a Perkin Elmer Sciex API 165 mass instrument. 
Optical rotations were measured on a Propol automatic polarimeter (sodium D line, λ = 589 nm). FT-
IR-spectra were recorded on a Paragon-PE 1000.  
 




To a solution of 10 (1.24 g, 3.65 mmol) in dichloromethane (26 mL) were added p-
toluenesulfonylchloride (1.04 g, 5.48 mmol, 1.1 equiv.) and triethylamine (0.90 mL, 6.57 mmol, 1.8 
equiv.) at 0°C. The solution was stirred for 5 h before being poured in 1M HCl solution. The mixture 
was extracted with Et2O and the organic layer was dried over MgSO4 before being concentrated in 
vacuo, yielding the crude tosylate which was immediately subjected to azidation. To a solution of 
tosylated intermediate (1.75 g, 3.65 mmol) in DMF (35 ml) was added sodium azide (2.40 g, 36.7 
mmol, 10.4 equiv.). The solution was stirred for 24 h at 60°C before being concentrated in vacuo. The 
crude product was diluted with EtOAc, washed with 1 M HCl, saturated aqueous NaHCO3 and brine. 
The combined organic layers were dried over MgSO4 and concentrated in vacuo. Purification by silica 
column chromatography (8%→16% EtOAc in petroleum ether) afforded 11 (900 mg, 2.46 mmol, 
71%) as an amorphous solid. 1H NMR (400 MHz, CDCl3): δ 7.33-7.26 (m, 10H), 5.79 (dt, J=10.4, 2.4 
Hz, 1H), 5.58 (dt, J=10.4, 2.4 Hz, 1H), 5.02 (d, J=11.3, 1H), 4.7 (dd, J=11.2, 5.4 Hz, 2H), 4.65 (d, 
J=11.2 Hz, 1H), 4.21-4.19 (m, 1H), 3.61-3.53 (m, 3H), 3.44 (dd, J=12.0, 6.0 Hz, 1H), 2.83 (s, 1H) and 
2.48 (br, 1H). 13C NMR (100 MHz, CDCl3): δ 138.1, 137.2, 128.7, 128.6, 128.0, 127.9, 127.8, 127.7, 
83.5, 80.3, 75.0, 71.6, 52.5 and 43.6. FT-IR: νmax (neat)/cm-1: 2095.9, 1497.1, 1453.9, 1275.9, 1092.6, 
1050.4, 1027.7, 732.0 and 695.9. [ ]20Dα  +137.8° (c=1, CHCl3). LC/MS: Rt 9.35; linear gradient 
10→90% B in 13.5 min; ESI/MS: m/z=383.1 [M+NH4]+. HRMS: (M+3H+-N2) calcd for C21H26NO3 
340.19072 found 340.19080. 
 
(1R,2R,3S,6R)-6-(azidomethyl)cyclohex-4-ene-1,2,3-triyl tribenzoate (12) 
Borontrichloride (21 mL, 1M in CH2Cl2, 21.1 mmol, 10 equiv.) was added to a solution of 11 (777.1 
mg, 2.11 mmol) in anhydrous dichloromethane (10 mL) at -78°C. The reaction mixture was stirred at -
78°C for 6 h before being quenched with MeOH. The solution was concentrated in vacuo giving the 
triol intermediate, which was immediately used for benzoylation. The crude product was coevaporated 
several times with anhydrous toluene before being dissolved in pyridine (10 mL). Benzoylchloride 
(2.6 mL, 21.1 mmol, 10 equiv.) was added at 0°C and the reaction mixture was stirred for 18 h at 
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ambient temperature. The mixture was quenched with saturated aqueous NaHCO3, extracted with 
EtOAc, dried over MgSO4 and concentrated in vacuo. Purification by silica column chromatography 
(4%→6% EtOAc in petroleum ether) afforded 12 (701.8 mg, 1.46 mmol, 70%) as a yellow oil. 1H 
NMR (400 MHz, CDCl3): δ 7.99 (d, J=7.2 Hz, 2H), 7.92 (d, J=7.2 Hz, 2H), 7.84 (d, J=7.2 Hz, 2H), 
7.53-7.46 (m, 3H), 7.40 (dt, J=24.4, 8.0 Hz, 5H), 7.26-7.18 (m, 2H), 6.00-5.93 (m, 3H), 5.86 (d, 
J=10.0 Hz, 1H), 5.72 (t, J=9.2 Hz, 1H), 3.64 (dd, J=12.4, 4.0 Hz, 1H), 3.46 (dd, J=12.4, 6.4 Hz, 1H) 
and 2.99-2.97 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 166.0, 165.9, 133.3, 133.2, 133.1, 129.8, 
129.7, 129.6, 129.4, 129.0, 128.9, 128.5, 128.4, 128.3, 126.2, 127.0, 72.7, 72.7, 72.6, 70.4, 52.0 and 
42.5. FT-IR: νmax (neat)/cm-1: 2100.3, 1718.0, 1601.8, 1585.4, 1492.2, 1314.5, 1250.8, 1178.0, 1108.8, 
1031.8, 1025.9, 950.7, 855.3, 778.1, 705.0 and 686.1. [ ]20Dα  +173° (c=1.0, CHCl3). LC/MS: Rt 10.68; 
linear gradient 10→90% B in 13.5 min; ESI/MS: m/z = 498.2 [M+H]+. HRMS: (M+Na+) calcd for 
C28H25NO6 520.14791 found 520.14724.  
 
(2S,3R,4S,5S)-2,3,4-Benzoyl-8-azido-8-deoxy-cyclophellitol (13 and 14) 
A solution of 0.4 mM Na2EDTA solution in H2O (3.1 mL) and trifluoroacetone (1.34 mL, 15 mmol, 
15 equiv.) were added to 12 (497 mg, 1.0 mmol) in acetonitrile (6.7 mL). A mixture of oxone (3.07 g, 
5.0 mmol, 5 equiv.) and NaHCO3 (588.1 mg, 7.0 mmol, 7 equiv.) was added to the solution over a 
period of 15 min. After stirring at 4°C for 4 h, an additional amount of 0.4 mM Na2EDTA in H2O (1.5 
mL), trifluoroacetone (0.7 mL, 7.5 mmol, 7.5 equiv.) and a mixture of oxone (1.5 g, 2.5 mmol, 2.5 
equiv.) and NaHCO3 (290 mg, 3.5 mmol, 3.5 equiv.) were added to the reaction mixture over a period 
of 15 min. The reaction mixture was stirred at 4°C for 30 min before being diluted with H2O. After 
extraction of the water layer with EtOAc, the combined organic layers were dried over MgSO4 and 
concentrated in vacuo. Purification by silica column chromatography (8%→10% Et2O in petroleum 
ether) and (16%→18% Et2O in petroleum ether) afforded 13 (103.9 mg, 0.20 mmol, 20%) and 14 
(253.7 mg, 0.49 mmol, 49%) respectively as amorphous solid.  
14: 1H NMR (400 MHz, CDCl3): δ 8.03 (d, J=7.4 Hz, 2H), 7.88 (d, J=7.6 Hz, 2H), 7.79 (d, J=7.6 Hz, 
2H), 7.56 (t, J=7.2 Hz, 1H), 7.46-7.36 (m, 5H), 7.32 (t, J=7.6 Hz, 2H), 7.24 (t, J=7.2, 2H), 5.84 (t, 
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J=9.2 Hz, 1H), 5.56 (d, J=8.8 Hz, 1H), 5.43 (t, J=10.0 Hz, 1H), 3.67-3.62 (m, 4H), 3.44 (s, 1H) and 
2.71 (dddd, J=9.3, 7.6, 1.4 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 165.7, 165.6, 165.4, 133.5, 133.3, 
133.1, 129.8, 129.6, 129.5, 128.9, 128.7, 128.6, 128.4, 128.3, 128.1, 72.2, 71.4, 67.8, 54.7, 54.2, 50.5 
and 40.8. FT-IR: νmax (neat)/cm-1: 2104.5, 1722.6, 1601.9, 1451.6, 1315.2, 1258.3, 1178.4, 1094.8, 
1069.6, 1026.1, 853.8, 706.6 and 686.1. [ ]20Dα  + 93.6° (c=1.0, CHCl3). LC/MS: Rt 10.24; linear gradient 
10→90% B in 13.5 min; ESI/MS: m/z = 514.2 [M+H]+.  HRMS: (M+H+) calcd for C28H23N3O7 
514.16088 found 514.16007.  
13: 1H NMR (400 MHz, CDCl3): δ 8.02 (d, J=7.2 Hz, 2H), 7.89 (d, J=7.2 Hz, 2H), 7.78 (d, J=7.2 Hz, 
2H), 7.53-7.19 (m, 5H), 5.96 (t, J=9.6 Hz, 1H), 5.77 (d, J=8.8 Hz, 1H), 5.55 (t, J=9.6 Hz, 1H), 3.77-
3.74 (m, 2H), 3.64 (dd, J=12.8, 4.0 Hz, 1H), 3.32 (s, 1H) and 2.68 (ddd, J=9.2, 5.2, 3.8 Hz, 1H). 13C 
NMR (100 MHz, CDCl3): δ 166.0, 165.9, 165.6, 133.4, 133.0, 129.9, 129.7, 129.5, 129.0, 128.9, 
128.6, 128.4, 128.3, 128.1, 72.1, 70.0, 69.9, 54.6, 53.8, 50.8  and 40.9. FT-IR: νmax (neat)/cm-1: 2104.6, 
1717.8, 1602.1, 1451.8, 1249.4, 1178.1, 1093.3, 1069.0, 1026.0 and 704.5. [ ]20Dα  +52.4° (c=1.0, 
CHCl3). LC/MS: Rt 10.22; linear gradient 10→90% B in 13.5 min; ESI/MS: m/z = 514.2 [M+H]+. 
HRMS: (M+H+) calcd for C28H23N3O7 514.16088 found 514.16017. 
  
(2S,3R,4S,5S)-8-azido-8-deoxy-cyclophellitol (KY170, 4) 
A catalytic amount of NaOMe was added to a solution of 14 (103.9 mg, 0.20 mmol) in MeOH (1.0 
mL) and stirred for 1 h at ambient temperature. The reaction mixture was neutralized with Amberlite 
IR-120 H+, filtered and concentrated in vacuo. Purification by silica column chromatrography 
(6%→8% MeOH in dichloromethane) provided KY170 4 (30.0 mg, 0.15 mmol, 75%). 1H NMR (400 
MHz, MeOD): δ 3.84 (dd, J=8.4, 3.6 Hz, 1H), 3.67 (d, J=8.0 Hz, 1H), 3.51 (dd, J=12.0, 8.8 Hz, 1H), 
3.36 (d, J=3.2 Hz, 1H), 3.23 (dd, J=10.0, 8.4 Hz, 1H), 3.13-3.08 (m, 2H), 2.07 (ddt, J=9.4, 3.6, 1.6 Hz, 
1H). 13C NMR (100 MHz, MeOD): δ 78.3, 72.7, 68.6, 57.6, 56.1, 52.4 and 43.9. FT-IR: νmax (neat)/cm-
1: 3331.7, 3187.9, 2936.1, 2097.6, 1455.8, 1345.9, 1273.4, 1144.2, 1092.5, 1066.5, 1032.1, 995.1, 
926.6, 899.8, 818.7, 803.5, 714.1 and 652.0. [ ]20Dα  + 174.7° (c=0.6, MeOH). LC/MS: Rt 0.95; linear 
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gradient 10→90% B in 13.5 min; ESI/MS: m/z = 219.2 [M+NH4]+. HRMS: (M+3H+-N2) calcd for 
C7H14NO4 176.09173 found 176.09179. 
 
MDW933 5  
KY170 4 (8.51 mg, 42 μmol) and BODIPY Green-alkyne 15 (13.8 mg, 42 μmol) (5) were dissolved in 
tert-BuOH/Tol/H2O (1.8 mL, 1/1/1 v/v/v). CuSO4 (100 mM in H2O, 42 μL, 4.2 μmol) and sodium 
ascorbate (100 mM in H2O, 63 μL, 6.3 μmol) were added. Subsequently, the reaction was heated to 
80°C and stirred overnight. The solution was diluted with CH2Cl2, washed with H2O, dried and 
concentrated. Purification over silica gel column chromatography (0%→5% MeOH/CH2Cl2) gave 
MDW933 5 as an orange powder (56%, 12.49 mg, 23.6 μmol).1H NMR (600 MHz, CDCl3) δ ppm 
7.40 (s, 1H), 6.01 (s, 2H), 4.68 (d, J = 12.0 Hz, 1H), 4.58 (dd, J = 13.4, 7.5 Hz, 1H), 3.66 (d, J = 5.6 
Hz, 1H), 3.40-3.34 (m, 1H), 3.20-3.15 (m, 1H), 3.02 (s, 1H), 2.97 (s, 1H), 2.96-2.91 (m, 2H), 2.73 (t, J 
= 6.4, 6.4 Hz, 2H), 2.49-2.46 (s, 6H), 2.45-2.40 (m, 1H), 2.33 (s, 6H), 1.86 (td, J = 15.0, 7.6, 7.6 Hz, 
2H), 1.66-1.58 (m, 2H). 13C NMR (150 MHz, CDCl3) δ ppm 153.9, 146.0, 140.3, 131.4, 121.7, 77.2, 
77.0, 76.9, 76.7, 71.1, 67.4, 56.0, 54.5, 49.6, 43.0, 31.2, 29.5, 28.1, 25.2, 16.3, 14.4. LC/MS: Rt 6.83; 
linear gradient 10→90% B in 13.5 min; ESI/MS: m/z = 530.00 [M+H]+. HRMS: (M+H+) calcd for 
C26H34BF2N5O4 530.27447 found 530.27454 
 
MDW941 6 
KY170 4 (5.46 mg, 27 μmol) and BODIPY Red-alkyne 16 (13.1 mg, 27 μmol) (5) were dissolved in 
tert-BuOH/Tol/H2O (1.5 mL, 1/1/1 v/v/v). CuSO4 (100 mM in H2O, 27 μL, 2.7 μmol) and sodium 
ascorbate (100 mM in H2O, 41 μL, 4.1 μmol) were added. Subsequently, the reaction was heated to 
80°C and stirred overnight. The solution was diluted with CH2Cl2, washed with H2O, dried and 
concentrated. Purification over silica gel column chromatography (0%→5% MeOH in 
dichloromethane) gave MDW941 6 as an purple powder (77%, 14.32 mg, 20.8 μmol).1H NMR (400 
MHz, CDCl3) δ ppm 7.80 (d, J = 8.5 Hz, 4H), 7.36 (s, 1H), 7.17 (d, J = 3.4 Hz, 2H), 6.89 (d, J = 8.5 
Hz, 4H), 6.54 (d, J = 3.8 Hz, 2H), 5.12-4.83 (m, 1H), 4.80-4.46 (m, 3H), 3.77 (s, 6H), 3.75-3.68 (m, 
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1H), 3.45-3.34 (m, 1H), 3.26-3.13 (m, 1H), 3.11-3.02 (m, 1H), 3.00-2.94 (m, 1H), 2.90-2.78 (m, 2H), 
2.73-2.58 (m, 2H), 2.51-2.36 (m, 1H), 2.08-1.91 (m, 2H), 1.84-1.67 (m, 4H). 13C NMR (150 MHz, 
CDCl3) δ ppm 160.5, 157.4, 144.6, 136.0, 130.9, 126.8, 125.0, 120.0, 113.7, 71.0, 67.2, 56.0, 55.2, 
54.6, 49.6, 42.7, 33.0, 30.3, 29.7, 29.4, 25.0. LC/MS: Rt 8.35; linear gradient 10→90% B in 13.5 min; 




Azide 11 (103 mg, 0.28 mmol) was dissolved in CH2Cl2 (5 mL) and cooled to -78ºC before BCl3 (5 
mL, 1M in CH2Cl2) was added. After 4 h stirring at -78°C, the reaction was quenched by the addition 
of MeOH. The temperature was raised to room temperature and the solution was concentrated in 
vacuo. Trace of BCl3 were removed by coevaporating with MeOH. The resulting crude triol 17 was 
used as such in the click reaction. 
 
MDW1064 (8) 
Azide 17 (37 mg, 0.15 mmol) was dissolved in DMF (2 mL). To the solution was added BODIPY 
Green-alkyne (82 mg, 0.25 mmol), CuSO4 (1M in H2O, 15 μL, 15 μmol) and sodium ascorbate (1M in 
H2O, 23 μL, 23 μmol). The reaction was stirred overnight, after which TLC analysis revealed 
complete conversion. The solution was diluted with EtOAc, washed with 1M HCl, NaHCO3 and brine, 
dried over Na2SO4 and concentrated under reduced pressure. Silica gel column chromatography 
(CH2Cl2→5% MeOH/CH2Cl2) afforded MDW1064 8 as an orange amorphous solid (72%, 55.3 mg, 
108 μmol). 1H NMR (400 MHz, CDCl3/MeOD) δ ppm 7.48 (s, 1H), 6.08 (s, 2H), 5.58 (td, J = 10.2, 
2.3, 2.3 Hz, 1H), 5.43 (td, J = 10.4, 2.0, 2.0 Hz, 1H), 4.61 (dd, J = 13.8, 3.8 Hz, 1H), 4.47 (dd, J = 
13.9, 7.3 Hz, 1H), 3.99-3.95 (m, 1H), 3.47 (dd, J = 9.9, 8.0 Hz, 1H), 3.30 (t, J = 9.7, 9.7 Hz, 1H), 
3.03-2.98 (m, 2H), 2.78 (t, J = 7.5, 7.5 Hz, 2H), 2.75-2.67 (m, 1H), 2.49 (s, 6H), 2.40 (s, 6H), 1.95-
1.86 (m, 2H), 1.74-1.64 (m, 2H). 13C NMR (150 MHz, CDCl3/MeOD) δ ppm 153.4, 146.8, 145.7, 
Nature Chemical Biology: doi: 10.1038/nchembio.466
23 
 
140.2, 130.9, 130.5, 125.0, 121.9, 121.3, 76.8, 71.6, 70.3, 50.6, 44.0, 30.9, 29.2, 27.6, 24.7, 15.7, 13.7. 
LC/MS: Rt 7.22; linear gradient 10→90% B in 13.5 min; ESI/MS: m/z=513.87 [M+H]+. 
 
MDW1065 (9) 
Azide 17 (33 mg, 0.15 mmol) was converted to the title compound as described above. To the solution 
was added BODIPY Red-alkyne (100 mg, 0.25 mmol), CuSO4 (1M in H2O, 15 μL, 15 μmol) and 
sodium ascorbate (1M in H2O, 23 µL, 23 μmol). The reaction was stirred overnight, after which TLC 
analysis revealed complete conversion. The solution was diluted with EtOAc, washed with 1M HCl, 
NaHCO3 and brine, dried over Na2SO4 and concentrated under reduced pressure. Silica gel column 
chromatography (CH2Cl2→5% MeOH/CH2Cl2) afforded title MDW1065 9 as a purple solid (70%, 71 
mg, 106 µmol). 1H NMR (400 MHz, CDCl3) δ ppm 7.89-7.78 (m, 4H), 7.36-7.27 (m, 1H), 7.27-7.21 
(m, 2H), 6.96-6.89 (m, 4H), 6.62-6.56 (m, 2H), 5.61-5.53 (m, 1H), 5.48-5.36 (m, 1H), 4.54-4.45 (m, 
2H), 4.01-3.93 (m, 1H), 3.86-3.79 (m, 6H), 3.50 (t, J = 8.8, 8.8 Hz, 1H), 3.29 (t, J = 9.6, 9.6 Hz, 1H), 
3.00-2.87 (m, 2H), 2.81-2.65 (m, 2H), 2.63-2.48 (m, 1H), 1.91-1.75 (m, 4H). 13C NMR (150 MHz, 
CDCl3) δ ppm 160.4, 157.4, 147.2, 144.6, 135.9, 130.8, 126.7, 125.4, 125.0, 122.0, 119.9, 113.6, 77.1, 
71.8, 70.3, 55.1, 50.8, 44.3, 32.9, 30.2, 29.2, 24.9. LC/MS: Rt 8.36; linear gradient 10→90% B in 13.5 
min; ESI/MS: m/z=670.00 [M+H]+. 
 
Determination of the binding constants 
To 100 µL McIlvaine buffer (pH 5.2, 0.2% sodium taurocholate, 0.1% Triton X-100) containing 4-
methylumbelliferyl β-D-glucoside (7.5 mM) in Greiner flat bottom black 96-well plate was added 5 
μL inhibitor (25× stock in DMSO). The resulting mixture was preincubated at 37°C for 15 min in a 
TECAN GENios microplate reader. GBA (2 ng) in McIlvaine buffer (20 μL pH 5.2, 0.2% sodium 
taurocholate, 0.1% Triton X-100) was preheated to 37°C for 15 min before being added to the 
substrate mix. The resulting solution was mixed by horizontal shaking for 15 sec, after which release 
4-methylumbelliferyl measured with a TECAN GENios platereader (λex 340 nm and λem 465 nm) for 
the indicated time. Bleaching of the fluorophore, which was observed during the assay, was corrected 
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by subtracting blanks (100 μL substrate buffer, 5 μL DMSO, 20 μL McIlvaine buffer). Apparent rate 
constants k’ were obtained by fitting the resulting progress curves (Figure 1A) to the one-phase 
association equitation 0'0max )exp1)(( yyyy tk +−−= − in GraphPad Prism version 5.00 for Windows, 
GraphPad Software, San Diego California USA, www.graphpad.com. Measurements were performed 
in nine fold and plotting of the obtained k’ values versus [I0] yielded rectangular hyperbolar functions 










kk  estimates of Ki app and ki were obtained. The Ki 
value in the absence of substrate was obtained by correcting the Ki app with )
][1(
mK
S+ . The Km of 4- 
methylumbelliferyl β-D-glucoside for GBA is 1.2 mM. 
 
Molecular docking  
KY170 4, MDW933 5, and MDW941 6 were docked on GBA as follows. Allowing conformational 
changes in the small compounds, enzyme-ligand complexes were simulated with a low free energy. 
Ligand molecules were prepared using MarvinSketch. Lowest energy conformers were calculated and 
saved as .pdb files that were used as input for AutodockTools. Rotatable bonds were defined and 
.pdbqt files were generated that served as input for Autodock Vina (7). Similarly, protein .pdbqt files 
were also prepared using AutodockTools. The protein file was produced from the crystal structure 
coordinates of glucocerebrosidase in the open state (pdb 2VE3,(8)). Autodock Vina experiments were 
run on a 2.66 GHz Intel duo core iMac computer (Apple Macintosh). Flexible docking experiments 
were run using standard settings apart from the exhaustiveness, which was set at 10. A search space 
spanning roughly 30 cubic Ångströms around the active site was defined.  
 
Time-lapse microscopy 
Fibroblasts were cultured in chamber slides (Lab-Tek II, Nunc, Roskilde, Denmark) and incubated 
with 5 nM compound MDW933 5 or MDW941 6; immediately after which mineral oil was thinly 
layered on top of the culture medium to prevent evaporation. With the 37°C, 10% CO2 incubator 
enclosing the microscope, cells were imaged every 5 min for 2 hours simultaneously using 
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fluorescence microscopy with an N2.1 filter block and phase-contrast brightfield microscopy (Leica 
IR-BE with Z-motor drive and a Plan APO 63×/1.40 oil immersion objective (Leica Microsystems, 
Rijswijk, The Netherlands), equipped with a KX85 camera, Apogee Instruments, Auburn, CA, USA). 
To minimize photo-toxicity fluorescence imaging was limited to 2 h; to monitor for possible toxicity 
due to the presence of MDW933 5 or MDW941 6, after 2 h live-cell imaging was continued with 
bright field microscopy only for another 98 hours. An auto-focus routine was applied during 
acquisition. Images were analyzed using TimeLapseAVI 5.1.4 software (©Ron Hoebe, CMO, AMC, 
University of Amsterdam, The Netherlands; R.A.Hoebe@amc.uva.nl). 
 
Mass spectrometric analysis of GBA labeled with KY170 4 and MDW933 5 
Identification of the site of binding of KY170 4 
GBA (5 μg) was labeled with 6 μM KY170 4 in McIlvaine buffer (150 mM, pH 5.2, 0.2% sodium 
taurocholate (w/v), 0.1% Triton X-100 (v/v)) for 1h at 37°C (10 μL end volume). Prior to digestion the 
pH was adjusted by the addition of 200 mM NH4HCO3 (pH 8.0), and the protein was reduced with 10 
mM dithiothreitol for 30 min at 60°C and alkylated with 15 mM iodoacetamide for 30 min at RT in 
the dark. The labeled protein was digested by addition of 50 ng trypsin (sequencing grade modified, 
Promega) and incubation at 37°C overnight. Protein digests were desalted using reversed phase C18-
Ziptips (2 μg capacity, Millipore). After activation in acetonitrile and loading of the samples, the 
Ziptips were washed with 0.1% aqueous trifluoroacetic acid and eluted with 60% acetonitrile, 0.1% 
trifluoroacetic acid and 39.9% water. Prior to loading onto the LC-MS system samples were diluted 
10-fold with 0.1% aqueous trifluoroacetic acid. 
Identification of the site of binding of MDW933 
Some 40 μg of recombinant GBA (1 μg/μL) was diluted in 60 μL McIlvaine buffer (150 mM, pH 5.2, 
0.2% sodium taurocholate (w/v), 0.1% Triton X-100 (v/v)), incubated with MDW933 5 (10 μL, 20 
μM stock in DMSO) for 1h at 37°C and precipitated with chloroform/methanol (C/M, (9)). The 
protein pellet was rehydrated in 90 μL 8 M urea/100 mM NH4HCO3, reduced with 5 μL 90 mM 
dithiothreitol for 30 min at 37°C, alkylated with 7.5 μL 200 mM iodoacetamide for 30 min at RT in 
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the dark and desalted by C/M. The pellet was dispersed in 100 μL 8 M urea/50 mM Na2CO3 buffer 
(pH 9.4). To 50 μL of the protein solution was added 5 μL hydroxylamine hydrochloride (10 M) and 
45 µL 8 M Urea/50 mM Na2CO3 buffer (pH 9.2). The pH was adjusted to pH ~9.2 by the addition of 
NaOH (5M). The resulting mixture was incubated overnight at 37°C, precipitated with C/M, 
redissolved in 10 μL 8 M urea/100 mM NH4HCO3, diluted with 90 μL digest buffer (100 mM Tris-
HCl pH 7.8, 100 mM NaCl, 1mM CaCl2, 2% ACN) and digested with 500 ng trypsin overnight at 
37°C. Peptides were collected and desalted on stage tips (10). 
LC-MS analysis 
Tryptic peptides were analyzed on a Surveyor nanoLC system (Thermo) hyphenated to a LTQ-
Orbitrap mass spectrometer (Thermo). Gold and carbon coated emitters (OD/ID=360/25μm tip ID=5 
μm), trap column (OD/ID=360/100 μm packed with 25 mm robust Poros®10R2/ 15 mm BioSphere 
C18 5 μm 120Å) and analytical columns (OD/ID=360/75 µm packed with 20 cm BioSphere C18 5 μm 
120Å) were from Nanoseparations (Nieuwkoop, The Netherlands). The mobile phases (A: 0.1% 
FA/H2O, B: 0.1%FA/ACN) were made with ULC/MS grade solvents (Biosolve). The emitter tip was 
coupled end-to-end with the analytical column via a 15 mm long TFE teflon tubing sleeve (OD/ID 
0.3×1.58 mm, Supelco, USA) and installed in a stainless steel holder mounted in a nano-source base 
(Upchurch scientific, Idex, USA).  
General mass spectrometric conditions were: an electrospray voltage of 1.8 kV was applied to the 
emitter, no sheath and auxiliary gas flow, ion transfer tube temperature 150°C, capillary voltage 41V, 
tube lens voltage 150V. Internal mass calibration was performed with air-borne protonated 
polydimethylcyclosiloxane (m/z = 445.12002) and the plasticizer protonated dioctyl phthalate ions 
(m/z = 391.28429) as lock mass (11).  
10 μL of the samples was pressure loaded on the trap column with a 10 μL/min flow for 5 min 
followed by peptide separation with a gradient of 35 min 5-30% B, 15 min 30-60% B, 5 min A at a 
flow of 300 μL/min split to 250 nL/min by the LTQ divert valve. For each data dependent cycle, one 
full MS scan (300-2000 m/z) acquired at high mass resolution (60,000 at 400 m/z, AGC target 1x106, 
maximum injection time 1,000 ms) in the Orbitrap was followed by 3 MS/MS fragmentations in the 
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LTQ linear ion trap (AGC target 5x103, max inj time 120 ms) from the three most abundant ions. MS2 
settings were: collision gas pressure 1.3 mT, normalized collision energy 35%, ion selection threshold 
of 500 counts, activation q = 0.25 and activation time of 30 ms. Fragmented precursor ions that were 
measured twice within 10 s were dynamically excluded for 60s and ions with z<2 or unassigned were 
not analyzed. Data from MS2 was validated manually. 
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